How to deal with cost differences at baseline

PharmacoEconomics

Volumn 27, Issue 6, 2009, Pages 519-528

  Van Asselt, Antoinette D I ^a   Van Mastrigt, Ghislaine A P G ^a   Dirksen, Carmen D ^a   Arntz, Arnoud ^b   Severens, Johan L ^a,b   Kessels, Alfons G H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORDERLINE STATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HUMAN; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHEMA FOCUSED THERAPY; TRANSFERENCE FOCUSED PSYCHOTHERAPY;

BORDERLINE PERSONALITY DISORDER; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; MODELS, ECONOMIC; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68349101851     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/00019053-200927060-00007     Document Type: Article

References (20)

1. Pocock SJ, Assmann SE, Enos LE, et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002 Oct 15; 21 (19): 2917-2930
2. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001 Apr 17; 134 (8): 657-662 (Pubitemid 32322244)
3. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001 Apr 17; 134 (8): 663-694 (Pubitemid 32322245)
4. Kleinbaum DG. Logistic regression: a self-learning text. Chapter 7. New York: Springer-Verlag, 1994
5. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 2004 Dec; 13 (12): 1203-1210 (Pubitemid 40017242)
6. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005 May; 14 (5): 487-496
7. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a nonparametric approach to confidence interval estimation. Health Econ 1997 Jul-Aug; 6 (4): 327-340
8. Efron B, Tibshirani RJ. An introduction to the bootstrap. London: Chapman & Hall, 1993
9. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005 Aug; 187: 106-108
10. Giesen-Bloo J, van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transferencefocused psychotherapy. Arch Gen Psychiatry 2006 Jun; 63 (6): 649-658
11. Arntz A, van den Hoorn M, Cornelis J, et al. Reliability and validity of the borderline personality disorder severity index. J Personal Disord 2003 Feb; 17 (1): 45-59 (Pubitemid 36343239)
12. Bland JM, Altman DG. Some examples of regression towards the mean. BMJ 1994 Sep 24; 309 (6957): 780 (Pubitemid 24291643)
13. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology, the essentials, chapter 2. 2nd ed. Baltimore (MD): Williams & Wilkins, 1988
14. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004 Oct; 9 (4): 197-204 (Pubitemid 39424759)
15. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, et al. Manual for cost research: methods and unit-prices for economic evaluations in health care - actualized version [in Dutch]. Diemen: College voor Zorgverzekeringen, 2004
16. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves: facts, fallacies and frequently asked questions. Health Econ 2004 May; 13 (5): 405-415
17. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999; 150 (4): 327-333
18. Severens JL, Mulder J, Laheij RJ, et al. Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in the Netherlands. Soc Sci Med 2000; 51 (2): 243-249 (Pubitemid 30209963)
19. van den Brink M, van Den Hout WB, Stiggelbout AM, et al. Self-reports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care 2005; 21 (3): 298-304
20. Oostenbrink JB, Al MJ. The analysis of incomplete cost data due to dropout. Health Econ 2005; 14: 763-776